Impact of miR-21, miR-126 and miR-221 as prognostic factors of clear cell renal cell carcinoma with tumor thrombus of the inferior vena cava

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Vergho, Daniel Claudius ^a   Kneitz, Susanne ^b   Kalogirou, Charis ^a   Burger, Maximilian ^c   Krebs, Markus ^a   Rosenwald, Andreas ^b   Spahn, Martin ^d   Löser, Andreas ^a   Kocot, Arkadius ^a   Riedmiller, Hubertus ^a   Kneitz, Burkhard ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 126; MICRORNA 141; MICRORNA 143; MICRORNA 200C; MICRORNA 21; MICRORNA 210; MICRORNA 221; MICRORNA LET 7B; UNCLASSIFIED DRUG; MESSENGER RNA; MIRN126 MICRORNA, HUMAN; MIRN21 MICRORNA, HUMAN; MIRN221 MICRORNA, HUMAN; TUMOR MARKER;

AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER TISSUE; CARCINOGENESIS; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC ANALYSIS; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFERIOR CAVA VEIN; KIDNEY CARCINOMA; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR THROMBUS; VALIDATION PROCESS; CANCER GRADING; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; FOLLOW UP; GENETICS; KIDNEY TUMOR; METABOLISM; MORTALITY; PAPILLARY CARCINOMA; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; THROMBOSIS;

AGED; BIOMARKERS, TUMOR; CARCINOMA, PAPILLARY; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; MALE; MICRORNAS; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; THROMBOSIS; VENA CAVA, INFERIOR;

EID: 84929361692     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109877     Document Type: Article

References (36)

1. Ljungberg B, Cowan NC, Hanbury DC, Hora M, Kuczyk MA, et al. (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58: 398-406.
2. Rini BI, Campbell SC, Escudier B (2009) Renal cell carcinoma. Lancet 373: 1119-1132.
3. Ciancio G, Livingstone AS, Soloway M (2007) Surgical management of renal cell carcinoma with tumor thrombus in the renal and inferior vena cava: the University of Miami experience in using liver transplantation techniques. Eur Urol 51: 988-994; discussion 994-985.
4. Klatte T, Pantuck AJ, Riggs SB, Kleid MD, Shuch B, et al. (2007) Prognostic factors for renal cell carcinoma with tumor thrombus extension. J Urol 178: 1189-1195; discussion 1195.
5. Haferkamp A, Bastian PJ, Jakobi H, Pritsch M, Pfitzenmaier J, et al. (2007) Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup. J Urol 177: 1703-1708.
6. Tilki D, Nguyen HG, Dall'era MA, Bertini R, Carballido JA, et al. (2013) Impact of Histologic Subtype on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus. Eur Urol: pii: S0302-2838(13)00663-5. doi: 10.1016/j.eururo.2013.06.048.
7. Vergho DC, Loeser A, Kocot A, Spahn M, Riedmiller H (2012) Tumor thrombus of inferior vena cava in patients with renal cell carcinoma - clinical and oncological outcome of 50 patients after surgery. BMC Res Notes 5: 5. doi: 10.1186/1756-0500-5-264.
8. Martinez-Salamanca JI, Huang WC, Millan I, Bertini R, Bianco FJ, et al. (2011) Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extension. Eur Urol 59: 120-127.
9. Sun M, Shariat SF, Cheng C, Ficarra V, Murai M, et al. (2011) Prognostic factors and predictive models in renal cell carcinoma: a contemporary review. Eur Urol 60: 644-661.
10. Laird A, O'Mahony FC, Nanda J, Riddick AC, O'Donnell M, et al. (2013) Differential expression of prognostic proteomic markers in primary tumour, venous tumour thrombus and metastatic renal cell cancer tissue and correlation with patient outcome. PLoS One 8: e60483.
11. Hui A, How C, Ito E, Liu FF (2011) Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies. BMC Cancer 11: 500. doi: 10.1186/1471-2407-11-500.
12. Catto JW, Alcaraz A, Bjartell AS, De Vere White R, Evans CP, et al. (2011) MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol 59: 671-681.
13. Vergho D, Kneitz S, Rosenwald A, Scherer C, Spahn M, et al. (2014) Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma. BMC Cancer 14: 25. doi: 10.1186/1471-2407-14-25.
14. Neves RJ, Zincke H (1987) Surgical treatment of renal cancer with vena cava extension. Br J Urol 59: 390-395.
15. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, et al. (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011, 12: 77.
16. Therneau TM, Grambsch PM (2000) Modeling Survival Data: Extending the Cox Model. Springer, New York. ISBN 0-387-98784-3.
17. Lossos IS, Czerwinski DK, Alizadeh AA, Wechser MA, Tibshirani R, et al. (2004) Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med 350: 1828-1837.
18. Wach S, Nolte E, Theil A, Stohr, et al. (2013) MicroRNA profiles classify papillary renal cell carcinoma subtypes. Br J Cancer 109: 714-722.
19. Youssef YM, White NM, Grigull J, Krizova A, Samy C, et al. (2011) Accurate molecular classification of kidney cancer subtypes using microRNA signature. Eur Urol 59: 721-730.
20. Grange C, Collino F, Tapparo M, Camussi G (2014) Oncogenic micro-RNAs and Renal Cell Carcinoma. Front Oncol 4: 49.
21. Faragalla H, Youssef YM, Scorilas A, Khalil B, White NM, et al. (2012) The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma. J Mol Diagn 14: 385-392.
22. Schaefer A, Stephan C, Busch J, Yousef GM, Jung K (2010) Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors. Nat Rev Urol 7: 286-297.
23. Slaby O, Jancovicova J, Lakomy R, Svoboda M, Poprach A, et al. (2012) Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy. J Exp Clin Cancer Res 29: 90.
24. White NM, Bao TT, Grigull J, Youssef YM, Girgis A, et al. (2011) miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. J Urol 186: 1077-1083.
25. Juan D, Alexe G, Antes T, Liu H, Madabhushi A, et al. (2010) Identification of a microRNA panel for clear-cell kidney cancer. Urology 75: 835-841.
26. Creighton CJ, Morgan M, Gunaratne PH, Wheeler DA, et al. (2013) Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499: 43-49.
27. Cho WC (2007) OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 6: 60.
28. Kneitz B, Krebs M, Kalogirou C, Schubert M, Joniau S, et al. (2014) Survival in high-risk prostate cancer patients is predicted by mir-221, which regulates proliferation, apoptosis and invasion of prostate cancer cells by inhibiting IRF2 and SOCS3. Cancer Res.
29. Schubert M, Spahn M, Kneitz S, Scholz CJ, Joniau S, et al. (2013) Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancer. PLoS One 8: e65064.
30. Heinzelmann J, Henning B, Sanjmyatav J, Posorski N, Steiner T, et al. (2011) Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma. World J Urol 29: 367-373.
31. Khella HW, White NM, Faragalla H, Gabril M, Boazak M, et al. (2012) Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses. Tumour Biol 33: 131-140.
32. Wotschofsky Z, Liep J, Meyer HA, Jung M, Wagner I, et al. (2012) Identification of metastamirs as metastasis-associated microRNAs in clear cell renal cell carcinomas. Int J Biol Sci 8: 1363-1374.
33. Jiang Z, Lohse CM, Chu PG, Wu CL, Woda BA, et al. (2008) Oncofetal protein IMP3: a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas. Cancer 112: 2676-2682.
34. Wu X, Weng L, Li X, Guo C, Pal SK, et al. (2012) Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis. PLoS One 7: e35661.
35. Sasahira T, Kurihara M, Bhawal UK, Ueda N, Shimomoto T, et al. (2012) Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer. Br J Cancer 107: 700-706.
36. Zaman MS, Shahryari V, Deng G, Thamminana S, Saini S, et al. (2012) Up-regulation of microRNA-21 correlates with lower kidney cancer survival. PLoS One 7: e31060.